First Valve-in-Valve TAVI in Delhi Using Abbott Navitor Vision 23 mm THV Platform – Performed by Dr. Gautam Naik

A New Milestone in Structural Heart Care

In a pioneering moment for interventional cardiology in Delhi, Dr. Gautam Naik has successfully performed the first Valve-in-Valve Transcatheter Aortic Valve Implantation (TAVI) using the Abbott Navitor Vision 23 mm THV platform. This breakthrough procedure marks a significant step forward in offering safer, less invasive treatment options for patients with failing bioprosthetic heart valves.


What is Valve-in-Valve TAVI?

Valve-in-valve TAVI is a catheter-based procedure designed to treat patients with degenerated surgical aortic bioprosthetic valves. Instead of undergoing a second open-heart surgery, the patient receives a new transcatheter valve implanted within the old one — reducing risks, hospital stay, and recovery time.

It is especially beneficial for patients who are:

  • Elderly or frail
  • High-risk for surgical intervention
  • Facing deteriorating symptoms due to valve failure

Why the Abbott Navitor Vision 23 mm THV?

The Navitor Vision from Abbott represents the next generation of self-expanding transcatheter valves, offering:

  • Low-profile access for ease of navigation through peripheral arteries
  • Active sealing to minimize paravalvular leaks
  • Improved radial strength and durability
  • Accurate deployment via the FlexNav™ delivery system

In this case, the 23 mm Navitor THV was perfectly suited for the patient’s prior valve dimensions and anatomy.


The Case: Performed by Dr. Gautam Naik

A patient with a previously implanted surgical aortic bioprosthesis began experiencing worsening symptoms due to valve stenosis and degeneration. After a comprehensive evaluation by the heart team, Dr. Gautam Naik, a leading expert in structural heart disease, performed the valve-in-valve TAVI via the transfemoral approach.

The outcome was exceptional — the new valve functioned immediately with minimal gradient and no paravalvular leak. The patient remained stable throughout and experienced significant symptomatic relief post-procedure.


Before & After: Real-Time Hemodynamic Success

Before TAVI Deployment

  • Aortic Pressure (AO): 128/52 mmHg
  • Left Ventricular Pressure (LV): 174/11 mmHg
  • A significant pressure gradient (LV >> AO) indicated critical aortic stenosis in the degenerated bioprosthetic valve.

After TAVI Deployment

  • Aortic Pressure (AO): 158/62 mmHg
  • Left Ventricular Pressure (LV): 157/9 mmHg
  • The post-TAVI readings show equalization of LV and AO pressures, confirming excellent valve performance and relief of obstruction.

Meet the Expert: Dr. Gautam Naik

Dr. Gautam Naik is a renowned Interventional and Structural Cardiologist practicing at Apollo Hospital, Delhi NCR. He has been at the forefront of complex heart procedures including:

  • TAVI / TAVR
  • MitraClip & transcatheter mitral interventions
  • Complex PCI and chronic total occlusions
  • Heart failure interventions

His expertise and commitment have made him a trusted name for minimally invasive heart treatments in India.


Conclusion: A New Era for Heart Valve Disease

The successful completion of Delhi’s first Valve-in-Valve TAVI using the Abbott Navitor Vision 23 mm THV is a testimony to the evolving capabilities of structural heart programs in India. It opens new doors for high-risk patients seeking advanced, less invasive solutions to valve failure.


💡 If you or a loved one has a failing surgical heart valve, consult Dr. Gautam Naik for a personalized evaluation.